Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
2.
Eur J Anaesthesiol ; 24(11): 934-41, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17568475

ABSTRACT

BACKGROUND AND OBJECTIVE: When intrathecally or epidurally administered, alpha2-adrenoceptor agonists produce potent antinociception by affecting the activity of primary afferent fibres and spinal cord neurons. Recent reports have indicated that in dorsal root ganglion neurons, tetrodotoxin-resistant Na+ channels play important roles in the conduction of nociceptive sensation. We therefore investigated the effects of alpha2-adrenoceptor agonists on tetrodotoxin-resistant Na+ currents. METHODS: Using the whole-cell patch-clamp technique, we recorded tetrodotoxin-resistant Na+ currents from rat dorsal root ganglion neurons. RESULTS: Both clonidine and dexmedetomidine reduced the peak amplitude of the tetrodotoxin-resistant Na+ current concentration- and use-dependently. The concentration required for a half-maximal effect was significantly lower for dexmedetomidine (58.0 +/- 10.2 micromol) than for clonidine (257.2 +/- 30.9 micromol) at holding potential -70 mV. The current inhibitions induced by these agonists were not prevented by 1 micromol yohimbine, an alpha2-adrenoceptor antagonist. Both clonidine and dexmedetomidine shifted the inactivation curve for the tetrodotoxin-resistant Na+ current in the hyperpolarizing direction. The combinations clonidine with lidocaine and dexmedetomidine with lidocaine produced an additive blockade-type interaction on the tetrodotoxin-resistant Na+ current. CONCLUSIONS: The results suggest that a direct inhibition of tetrodotoxin-resistant Na+ channels may contribute to the antinociceptive effects of clonidine and dexmedetomidine when used as additives to regional anaesthesia.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Anesthetics, Local/pharmacology , Ganglia, Spinal/drug effects , Neurons/drug effects , Receptors, Adrenergic, alpha-2/administration & dosage , Sodium Channel Blockers/pharmacology , Sodium Channels/drug effects , Tetrodotoxin/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Algorithms , Animals , Clonidine/pharmacology , Dexmedetomidine/pharmacology , Dose-Response Relationship, Drug , Drug Resistance , Ganglia, Spinal/cytology , Lidocaine/pharmacology , Membrane Potentials/drug effects , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , Yohimbine/pharmacology
3.
Eur J Anaesthesiol ; 24(9): 782-8, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17462118

ABSTRACT

BACKGROUND AND OBJECTIVE: To examine a possible mechanism for the antinociceptive action of the N-methyl-D-aspartate receptor antagonist ifenprodil, we compared its effects with those of ketamine on tetrodotoxin-resistant Na+ channels in rat dorsal root ganglion neurons, which play an important role in the nociceptive pain pathway. METHODS: Experiments were performed on dorsal root ganglion neurons from Sprague-Dawley rats, recordings of whole-cell membrane currents being made using patch-clamp technique. RESULTS: Both drugs blocked tetrodotoxin-resistant Na+ currents dose dependently, their half-maximal inhibitory concentrations being 145+/-12.1 micromol (ketamine) and 2.6+/-0.95 micromol (ifenprodil). Ifenprodil shifted the inactivation curve for tetrodotoxin-resistant Na+ channels in the hyperpolarizing direction and shifted the activation curve in the depolarizing direction. Use-dependent blockade of tetrodotoxin-resistant Na+ channels was more marked with ifenprodil than with ketamine. When paired with lidocaine, these drugs produced similar additive inhibitions of tetrodotoxin-resistant Na+ channel activity. CONCLUSIONS: The observed suppressive effects on tetrodotoxin-resistant Na+ channel activity may, at least in part, underlie the antinociceptive effects of these N-methyl-D-aspartate receptor antagonists.


Subject(s)
Adrenergic alpha-Antagonists/pharmacology , Neurons, Afferent/drug effects , Nociceptors/drug effects , Piperidines/pharmacology , Sodium Channels/drug effects , Analgesics/pharmacology , Anesthetics, Local/pharmacology , Animals , Dose-Response Relationship, Drug , Ganglia, Spinal/cytology , Ganglia, Spinal/metabolism , Ion Channel Gating , Ketamine/pharmacology , Lidocaine/pharmacology , Male , Membrane Potentials/drug effects , Neurons, Afferent/metabolism , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , Tetrodotoxin/pharmacology
4.
Health Phys ; 83(4): 519-25, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12240727

ABSTRACT

An access-control system has been developed and installed at the National Institute for Fusion Science. The system uses an interlock-signal system and a group-access-control system to safeguard the operation of the large helical device. In this paper, the access-control system is described along with its features, advantages and disadvantages, and benefits.


Subject(s)
Environmental Exposure/prevention & control , Occupational Exposure/prevention & control , Occupational Health , Particle Accelerators , Radiation Monitoring/methods , Security Measures , Humans , Software
5.
Skull Base Surg ; 10(4): 211-6, 2000.
Article in English | MEDLINE | ID: mdl-17171150

ABSTRACT

THIS ARTICLE OUTLINES A NEW SURGICAL TECHNIQUE FOR ACCESSING THE ORBITAL ROOF: the transpalpebral approach. It involves making an incision on the double fold of the upper eyelid, then dissecting the orbital septum and the orbicular muscle of the eye. This exposes the orbital roof and enables the surgeon to approach without a coronal incision of the scalp; the direct eyelid incision provides adequate workspace. We use this approach in three orbital roof fractures and one orbital hemangioma. This orbital approach offers a simpler surgical technique, a less invasive one, and still provides excellent exposure of the superior orbital cavity.

6.
Clin Investig ; 72(5): 377-80, 1994 May.
Article in English | MEDLINE | ID: mdl-7522067

ABSTRACT

An autopsy case of an 83-year-old Japanese woman with pancreatic cancer with significantly elevated serum alpha-fetoprotein levels is reported. The pancreatic tumor was a mucinous cystadenocarcinoma with multiple metastasis to the liver. The immunohistochemistry for alpha-fetoprotein revealed positive reactivity in the cytoplasm of cancer cells in the primary and liver metastatic lesions. The current case is the first reported in which mucinous cystadenocarcinoma of the pancreas produced alpha-fetoprotein.


Subject(s)
Cystadenocarcinoma, Mucinous/metabolism , Neoplasm Proteins/metabolism , Pancreatic Neoplasms/metabolism , alpha-Fetoproteins/metabolism , Aged , Cystadenocarcinoma, Mucinous/pathology , Cystadenocarcinoma, Mucinous/secondary , Fatal Outcome , Female , Humans , Liver Neoplasms/secondary , Pancreatic Neoplasms/pathology
8.
Endocrinol Jpn ; 38(2): 121-9, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1661231

ABSTRACT

In an attempt to investigate the clinical significance of anti-pituitary antibodies in patients with hypopituitarism, anti-pituitary antibody in plasma was examined in 10 such patients (7 cases of isolated ACTH deficiency, 1 of partial hypopituitarism, and 2 of Sheehan's syndrome), on two or three occasions with an interval of more than 6 months (longitudinal study). In a total of 16 relatives of these 4 patients (2 cases of Sheehan's syndrome, one in each of partial hypopituitarism and isolated ACTH deficiency) and one patient not involved in the longitudinal study, anti-pituitary antibodies were also examined (family study). Anti-pituitary antibodies reacting with rat pituitary cytoplasmic antigens (pituitary cell antibodies: PCA) and pituitary cell surface antibodies (PCSA) reacting with GH3 cells and/or AtT-20 cells were measured with indirect immunofluorescence. The longitudinal study revealed the disappearance of antibodies in 3 patients, 2 PCA positive and one both PCA and PCSA positive. In 3 patients, altered antibody titers or a newly appearing antibody were found during the follow-up period. In 4 patients, the pituitary antibodies were negative during the follow-up periods. Of 16 family members studied, positive PCA was found in 3 members (2 in the families of patients with PCA positive Sheehan's syndrome, and 1 in the family of the patients with PCA positive partial hypopituitarism). Positive PCSA was found in 4 members (one in each of families of patients with partial hypopituitarism and isolated ACTH deficiency and of two cases of Sheehan's syndrome), and weakly positive PCSA was found in one family member of a patients with PCA positive Sheehan's syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Hypopituitarism/immunology , Pituitary Gland/immunology , Adrenocorticotropic Hormone/deficiency , Adult , Antigens, Surface/immunology , Autoantibodies/analysis , Female , Follicle Stimulating Hormone/blood , Growth Hormone/blood , Humans , Hydrocortisone/blood , Hypopituitarism/genetics , Longitudinal Studies , Luteinizing Hormone/blood , Male , Middle Aged , Pedigree , Prolactin/blood , Thyrotropin/blood
9.
Appl Microbiol Biotechnol ; 33(6): 629-32, 1990 Sep.
Article in English | MEDLINE | ID: mdl-1366943

ABSTRACT

A yeast lytic enzyme was covalently immobilized on an enteric coating polymer, Eudragit S, that is reversibly soluble and insoluble (S-IS) depending on the pH of the reaction medium. The yeast lytic enzyme immobilized on Eudragit S (Y-E) showed a sharp response of solubility to slight changes in pH without decrease in enzymatic activity. The specific activity per amount of enzyme protein of Y-E for dry yeast cells was about two-thirds that of the native enzyme. In both lysis reactions of dry and pressed baker's yeast cells, changing the pH of the reaction medium from 7.0 to 4.8 at an appropriate interval allows the insoluble Y-E and the reaction products (soluble protein for dry yeast cells and invertase and soluble protein for pressed baker's yeast cells) to be repeatedly separated. The reaction method using a reversible S-IS enzyme is a promising procedure for repeated use of the enzyme in a heterogeneous reaction system containing yeast cells as a substrate.


Subject(s)
Enzymes, Immobilized/chemistry , Hydrolases/chemistry , Yeasts , Acrylic Resins , Enzymes, Immobilized/metabolism , Glycoside Hydrolases/metabolism , Hydrogen-Ion Concentration , Hydrolases/metabolism , Hydrolysis , Polymethacrylic Acids , Substrate Specificity , beta-Fructofuranosidase
SELECTION OF CITATIONS
SEARCH DETAIL
...